ATF6 and Miyoshi myopathy: Even though UPR activity is essential for MM survival in a context-dependent manner, reduced ATF6 expression and ER lumen width has been associated with BTZ resistance in KMS-11 resistant cells, leading to pitfalls in MM therapy (Figure 4) [176].